Please login to the form below

Not currently logged in
Email:
Password:

Alexion boosts rare disease portfolio with $8.4bn Synageva buy

Deal will help bolster firm's offering which is currently headed by aHUS drug Soliris

EMA to stop ‘revolving doors’ committee members

EU flagComes nearly five years after its former director left for a pharma service firm

Heart drug sales continue downward spiral

AstraZeneca Crestor rosuvastatin But revenue has stabilised after a tough three years of patent expiries

GSK files immune deficiency gene therapy in Europe

GSK - logo on buildingTherapy designed to correct ADA deficiency

Schultz takes Lundbeck helm after leaving Novo Nordisk

Former executive left Danish firm just days ago

China to relax pricing curbs from June

Reports suggest medicine sales could reach $185bn in the region by 2018

Shire enters research partnership for rare eye disease

Shire BasingstokeWill work with Foundation Fighting Blindness on treatment for adRP

Cancer drug spend tops $100bn in 2014

Roche Avastin bevacizumab cancerBut payers are starting to bulk at increasing prices

More money for the NHS – but is this the answer?

Politicians opening their pre-election cheque books can’t put the UK’s health service where it needs to be – but pharma could have a major role to play

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

blog-icon-webinar-storytelling.png
Webinar recording: The storytelling method that works for e-detailing
If you can involve healthcare professionals in a story, they will be more open to your arguments....
MORE MONEY FOR THE NHS – BUT IS THIS THE ANSWER?
Paul Mannu of Cello Health Insight says that politicians opening their pre-election cheque books can’t put the NHS where it needs to be – but pharma can play a major...
Medius Deal Watch
Pharma deals in February 2015
Pfizer and Valeant led the way during a respectable, if not record-breaking, month for mergers, acquisitions and collaborations...

Infographics